Mass Personalization for Medical Device Therapy

whitePaper | November 19, 2022

Among other industry-defining changes, the COVID-19 pandemic transformed the experience patients have come to expect from their healthcare providers.

whitePaper | January 14, 2022

Advanced Therapy Medicinal Products (ATMPs) are at the forefront of global scientific innovation in healthcare. These pioneering treatments, which include gene therapies, somatic cell therapies and tissue engineered products, have the potential to transform patients’ lives

whitePaper | December 27, 2022

It used to be a guessing game if patients would show up for scheduled appointments at Wayne HealthCare. At this acute care system in Greenville, Ohio, patient access was clunky.

whitePaper | May 25, 2022

Is the long-awaited seismic shift in health care finally here? A collision of forces—a global pandemic of historic proportions; exponential advances in medical science; an explosion of digital technologies,

whitePaper | November 24, 2022

Please keep this valuable booklet nearby. You’ll need it to look up the OTC items you want to order.

whitePaper | March 4, 2020

Health leaders must understand the benefits of their investments in performance improvement projects and the impact on the organization. The traditional approach is most often to measure ROI (return on investment) and, while clearly measurable, is most often related to cost savings or increased revenue and can leave you with an incomplete story. Incorporating VOI (value on investment) enables you to quantify the intangible benefits of your projects and activities making the combination of the two a more robust indicator of project success.